Cingulate Inc.
CING- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001862150
No open-market purchases or sales by Cingulate Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $9.88M in total; no superinvestor holds it.
Other share classesCINGW
Q2 2026 vs. Q1 2026
How the institutions holding Cingulate Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 27 | 32 | +5 |
| Shares | 1.19M | 1.83M | +641.8K (+54.0%) |
| Value | $7.37M | $9.88M | +$2.52M (+34.2%) |
New holders (9)
Institutions that held Cingulate Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Raymond James Financial Inc | 166,898 | $912.9K | 0.00% |
| Jump Financial, LLC | 14,638 | $80.1K | 0.00% |
| PKS Advisory Services, LLC | 11,500 | $62.9K | 0.01% |
| IFP Advisors, Inc | 2,000 | $10.9K | 0.00% |
| Jones Financial Companies LLLP | 2,000 | $9.92K | 0.00% |
| Barclays PLC | 1,566 | $8.57K | 0.00% |
| Wells Fargo & Company | 1,000 | $5.47K | 0.00% |
| Rialto Wealth Management, LLC | 102 | $558 | 0.00% |
| Avion Wealth | 112 | $0 | 0.00% |
Sold out (4)
Institutions that held Cingulate Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Marshall Wace, LLP | 92,934 | $577.1K |
| Quadrature Capital Ltd | 34,839 | $216.3K |
| HRT Financial LP | 33,144 | $205.0K |
| Soltis Investment Advisors LLC | 16,442 | $102.1K |